Low-dose human recombinant interferon-α-2c ARG (Hu-rIFN-α) in hairy cell-leukemia (HCL): design, recruitment and first observations in a prospective randomized multicenter trial | Zendy

AI Assistant Blog Pricing

Low-dose human recombinant interferon-α-2c ARG (Hu-rIFN-α) in hairy cell-leukemia (HCL): design, recruitment and first observations in a prospective randomized multicenter trial

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.